Literature DB >> 2014287

Abnormal testicular function: potential of P-31 MR spectroscopy in diagnosis.

J van der Grond1, J S Laven, E R te Velde, W P Mali.   

Abstract

Phosphorus-31 MR spectroscopy of the human testis was performed on healthy volunteers (n = 17) and oligospermic (n = 7) and azoospermic patients (n = 4). All patients in the latter group had the Sertoli-cell-only syndrome. Determination of the ratios of phosphomonoesters (PMs) to adenosine triphosphate (ATP), phosphodiesters (PDs) to ATP, and inorganic phosphate (Pi) to ATP made it possible to discriminate among these three groups. The testicular PM/ATP ratio was 1.71 +/- 0.03 (mean +/- standard deviation) in the healthy volunteers and dropped to 1.41 +/- 0.06 (P less than .001 in comparison with healthy volunteers) in the oligospermic patients and to 1.22 +/- 0.07 (P less than .001) in the azoospermic patients. The testicular PD/ATP ratio did show a slight increase from 0.52 +/- 0.10 in healthy volunteers to 0.68 +/- 0.09 (not significant) for oligospermic patients and to 0.83 +/- 0.10 (P less than .01) for azoospermic patients. The Pi/ATP ratio did not show significant differences between healthy volunteers (0.12 +/- 0.07) and oligospermic patients (0.23 +/- 0.08) but was elevated in the azoospermic patients (0.79 +/- 0.12) (P less than .001).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014287     DOI: 10.1148/radiology.179.2.2014287

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  MR Spectra of Normal Adult Testes and Variations with Age: Preliminary Observations.

Authors:  Athina C Tsili; Loukas G Astrakas; Alexandra Ntorkou; Dimitrios Giannakis; Sotirios Stavrou; Vasilios Maliakas; Nikolaos Sofikitis; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2015-10-16       Impact factor: 5.315

2.  Immobilization Technique for High-Resolution MR Imaging of the Testes.

Authors:  Masayuki Yamaguchi; Hirofumi Fujii
Journal:  Magn Reson Med Sci       Date:  2018-01-18       Impact factor: 2.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.